These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 3913889

  • 21. Empiric monotherapy in neutropenia: a realistic goal?
    Del Favero A, Bucaneve G, Menichetti F.
    Scand J Infect Dis Suppl; 1995; 96():34-7. PubMed ID: 7652501
    [Abstract] [Full Text] [Related]

  • 22. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
    Lorente L, Jiménez A, Palmero S, Jiménez JJ, Iribarren JL, Santana M, Martín MM, Mora ML.
    Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
    [Abstract] [Full Text] [Related]

  • 23. [Ceftazidime: review of the microbiological and clinical experience].
    Arosio E, Pancera P, Montesi G.
    Recenti Prog Med; 1985 Dec; 76(12):635-42. PubMed ID: 3914016
    [No Abstract] [Full Text] [Related]

  • 24. [Dibekacin in bronchopulmonary infectious pathology].
    Gouin F, Basse F, Robert D, Auboyer C.
    Nouv Presse Med; 1982 Nov 18; 11(46):3447-50. PubMed ID: 7155856
    [Abstract] [Full Text] [Related]

  • 25. Imipenem/cilastatin as monotherapy in the treatment of acute or chronic lung infections: clinical efficacy and safety.
    Sanduzzi A, Nani E, Giacomelli P, Amato G, Bariffi F.
    J Chemother; 1989 Jul 18; 1(4 Suppl):762-3. PubMed ID: 16312627
    [No Abstract] [Full Text] [Related]

  • 26. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Pérez C, Sirham M, Labarca J, Grebe G, Lira P, Oliva J, Duhalde M, Ocqueteau M, Acuña G.
    Rev Med Chil; 1995 Mar 18; 123(3):312-20. PubMed ID: 8525170
    [Abstract] [Full Text] [Related]

  • 27. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an Intensive Care Unit in Greece.
    Ntagiopoulos PG, Paramythiotou E, Antoniadou A, Giamarellou H, Karabinis A.
    Int J Antimicrob Agents; 2007 Oct 18; 30(4):360-5. PubMed ID: 17629680
    [Abstract] [Full Text] [Related]

  • 28. The use of cefotaxime in pneumology.
    Grassi C, Colombo ML, Peona V.
    Acta Med Port; 1983 Feb 18; 4(2):87-90. PubMed ID: 6303060
    [No Abstract] [Full Text] [Related]

  • 29. [Metronidazole in the treatment of pleuropulmonary infections due to anaerobic germs].
    Ispas LT, Vainer E, Socoşan G.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1984 Feb 18; 33(4):361-70. PubMed ID: 6097995
    [No Abstract] [Full Text] [Related]

  • 30. Donor-transmitted bacterial infection in heart-lung transplantation.
    Ciulli F, Tamm M, Dennis C, Biocina B, Mullins P, Wells FC, Large SR, Wallwork J.
    Transplant Proc; 1993 Feb 18; 25(1 Pt 2):1155-6. PubMed ID: 8442069
    [No Abstract] [Full Text] [Related]

  • 31. [Ceftriaxone in the ambulatory treatment of bacterial infections].
    Santa Cruz Valverde PL, Cruz Abascal R.
    Med Clin (Barc); 1993 May 08; 100(18):718. PubMed ID: 8492604
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS, Frei CR.
    J Antimicrob Chemother; 2005 Nov 08; 56(5):893-8. PubMed ID: 16162664
    [Abstract] [Full Text] [Related]

  • 33. Ceftazidime (Fortaz).
    Med Lett Drugs Ther; 1985 Oct 11; 27(698):85-7. PubMed ID: 3900663
    [No Abstract] [Full Text] [Related]

  • 34. Branhamella catarrhalis: an unappreciated pulmonary pathogen.
    Roth RM, Gleckman RA, Hibert DM.
    Am Fam Physician; 1984 Oct 11; 30(4):169-73. PubMed ID: 6333806
    [Abstract] [Full Text] [Related]

  • 35. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial.
    Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE.
    J Antimicrob Chemother; 2005 Jan 11; 55(1):90-4. PubMed ID: 15574481
    [Abstract] [Full Text] [Related]

  • 36. [Retrosternal administration of antibiotics as a method of choice in regional lymphotropic therapy].
    Korepanov KM, Strelkov GN.
    Ross Med Zh; 1992 Jan 11; (1):43-4. PubMed ID: 1611271
    [No Abstract] [Full Text] [Related]

  • 37. Clinical assay of ceftazidime levels in tissues of the relatively ischaemic limb.
    Smith RM, Stewart J, Kester RC, Ramsden CH.
    Br J Clin Pract; 1985 Mar 11; 39(3):94-7. PubMed ID: 3885991
    [No Abstract] [Full Text] [Related]

  • 38. [Ceftazidime: a new cephalosporin of broad spectrum].
    Gandulla LM.
    Medicina (B Aires); 1986 Mar 11; 46(3):341-51. PubMed ID: 3553840
    [No Abstract] [Full Text] [Related]

  • 39. [Amino acids and anabolic steroids in the treatment of suppurative diseases of the lungs].
    Korepanov AM, Kurnikova IA.
    Klin Med (Mosk); 1987 Feb 11; 65(2):61-4. PubMed ID: 3573707
    [No Abstract] [Full Text] [Related]

  • 40. Anaerobic lung infections treated with doxycycline.
    Thadepalli H, Webb D, Huang JT.
    Bull N Y Acad Med; 1978 Feb 11; 54(2):165-76. PubMed ID: 272211
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.